Statements not achieving consensus when agree and strongly agree is combined as one answer

StatementResponses: agree or strongly agree
When a patient presents with new respiratory symptoms while using a medication known to cause DI-ILD, initial investigations and management should focus around more common causes of symptoms16 (49%)
Pulsed i.v. cyclophosphamide should be considered in those patients not responding to i.v. methylprednisolone or oral prednisolone14 (42%)
In patients responding to therapy, follow-up should occur within 6 weeks of initial therapy24 (73%)
If a drug has been proven, or is highly suspected, to have caused DI-ILD, if no alternative agent is available and treatment is absolutely required, the offending drug should be cautiously reintroduced ideally at reduced dosage and with frequent monitoring (1–2 weekly)19 (58%)

DI-ILD: drug-induced interstitial lung disease.